US › Healthcare

Moolec Science SA Ordinary Shares (MLEC)

US · Healthcare · Biotechnology

$1.68-10.16%

Last close · 2026-10-16

Latest quarter · ended 2025-03-31

Revenue

$2.6M

Revenue YoY

+25.3%

Net profit

$-2.4M

EPS

$0.00

EPS estimate

$-0.06

Net margin

-91.8%

EPS came in at 0.00 against a street estimate of -0.06 — a beat of 100.0%.

Key statistics

Market cap

$1.4M

Forward P/E

0.0

P/B

0.49

Book value

$0.70

EPS (TTM)

$-209.62

52-week high

$23.22

52-week low

$1.50

50-day MA

$6.04

200-day MA

$7.40

Beta

-0.32

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

21.06%

Institutions

0.07%

Largest institutional holders

Fund	Stake
UBS Group AG	0.06%
Caitong International Asset Management Co., Limited.	0.00%
SBI Securities Co Ltd	0.00%
HRT FINANCIAL LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Moolec Science SA Ordinary Shares — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.